1
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Intracavernous Injections in the Management of Diabetic Impotence

, , , , , , & show all
Pages 126-136 | Published online: 22 Jan 2015

  • Abelson, D. (1971). Diagnostic value of the penile pulse and blood pressure: A Doppler study of impotence in diabetics. Journal of Urology, 113, 636–639.
  • Althof, S. E., Turner, L. A., Levine, S. B., (1987). Intracavernosal injection in the treatment of impotence: A prospective study of sexual, psychological, and marital functioning. Journal of Sex and Marital Therapy, 13, 155–167.
  • Brindley, G. S. (1986). Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection. British Journal of Psychology, 149, 210–215.
  • Buvat, J., Lemaire, A., Buvat-Herbaut, M., Guieu, J. D., Bailleul, J. P., & Fossati, P. (1985). Comparative investigations in 26 impotent and 26 nonimpotent diabetic patients. Journal of Urology, 133, 34–38.
  • Ellenberg, M. (1971). Impotence in diabetes: The neurologic factor. Annals of Internal Medicine, 75, 213–219.
  • Faerman, I., Glocer, L., Fox, D., (1974). Impotence and diabetes: Histological studies of the autonomic nervous fibers of the corpora cavernosa in impotent diabetic males. Diabetes, 23, 971–976.
  • Gaskell, P. (1971). The importance of penile blood-pressure in cases of impotence. Canadian Medical Association Journal, 105, 1047–1051.
  • Janosko, E. (1986). Intracavernous self-injection of papaverine and regitine for the treatment of organic impotence. North Carolina Medical Journal, 47, 305–307.
  • Jensen, S. B. (1982). Sexual function in 20 younger insulin-treated male diabetic outpatients: A two year follow-up study. Sexuality and Disability, 3, 61–67.
  • Kinsey, A. C., Pomeroy, W. B., & Martin, C. E. (1948). Sexual behavior in the human male. Philadelphia: W. B. Saunders.
  • Kolodny, R. C., Kahn, C. B., Goldstein, H. H., & Barnett, D. M. (1973). Sexual dysfunction in diabetic men. Diabetes, 23, 306.
  • Koncz, L., & Balodimos, M. C. (1970). Impotence in diabetes mellitus. Medical Times, 98, 159–170.
  • Lehman, T. P., & Jacobs, J. A. (1983). Etiology of diabetic impotence. Journal of Urology, 129, 291–294.
  • Levine, S. B., Althof, S. B., Turner, L. A., (1989). Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. Journal of Urology, 141, 54–57.
  • Lue, T., & Tanagho, E. (1987). Physiology of erection and pharmacological management of impotence. Journal of Urology, 137, 829–836.
  • Malloy, T., & Malkovicz, B. (1987). Pharmacologic treatment of impotence. Urological Clinics of North America, 14, 297–305.
  • Martin, L. M. (1981). Impotence in diabetes: An overview. Psychosomatics, 22, 318–329.
  • Melman, A., & Henry, D. (1979). The possible role of the catecholamines of the corpora in penile erection. Journal of Urology, 121, 419–421.
  • Robinette, M., & Moffat, M. (1986). Intracorporal injection of papaverine and phentolamine in the management of impotence. British Journal of Urology, 58, 692–695.
  • Rubin, A., & Babbott, O. (1958). Impotence and diabetes mellitus. Journal of the American Medical Association, 168, 498–500.
  • Ruzbarsky, V., & Michal, V. (1977). Morphologic changes in the arterial bed of the penis with aging. Investigative Urology, 15, 194–199.
  • Sidi, A. A., Cameron, J. S., Duffy, I. M., & Lange, P. H. (1986). Intracavernous drug-induced erections in the management of male erectile dysfunction: Experience with 100 patients. Journal of Urology, 135, 704–706.
  • Tattersall, R. (1975). Sexual problems of diabetic men. British Medical Journal, 285, 911–912.
  • Turner, L. A., & Althof, S. E. (n.d.). Case Western Reserve University sexual functioning questionnaire. Unpublished instrument.
  • Virag, R., Frydman, D., Legman, M., & Virag, H. (1984). Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology, 35, 79–87.
  • Zorgniotti, A. W., & Lefleur, R. S. (1985). Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. Journal of Urology, 133, 39–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.